Abbott Laboratories (ABT)

Company Profile

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Company profile

Ticker

ABT

Exchange

NYSE

Website

www.abbott.com

CEO

Robert Ford

Incorporated

Illinois

Location

Illinois

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies • Celgene ...

SEC CIK

0000001800

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Natural Supplement Association, LLC • Abbott Laboratories Co. Canada • Alere Connected Health LTD • Alere UK Holdings Limited ...

IRS number

360698440

ABT stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$128.00

Low target

$116.00

High target

$136.00

Latest filings (excl ownership)

View all

Conflict minerals disclosure

4 May 23

Automatic shelf registration

3 May 23

8-K

Submission of Matters to a Vote of Security Holders

2 May 23

8-K

Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

19 Apr 23

PX14A6G

Letter to shareholders

10 Apr 23

PX14A6G

Letter to shareholders

4 Apr 23

ARS

2022 FY

Annual report to shareholders

17 Mar 23

DEFA14A

Additional proxy soliciting materials

17 Mar 23

DEF 14A

Definitive proxy

17 Mar 23

Transcripts

View all

ABT

Earnings call transcript

2023 Q1

19 Apr 23

ABT

Earnings call transcript

2022 Q4

25 Jan 23

ABT

Earnings call transcript

2022 Q3

19 Oct 22

ABT

Earnings call transcript

2022 Q2

20 Jul 22

ABT

Earnings call transcript

2022 Q1

20 Apr 22

ABT

Earnings call transcript

2021 Q4

26 Jan 22

ABT

Earnings call transcript

2021 Q3

20 Oct 21

ABT

Earnings call transcript

2021 Q2

22 Jul 21

ABT

Earnings call transcript

2020 Q4

20 Apr 21

ABT

Earnings call transcript

2020 Q4

27 Jan 21

Latest ownership filings

View all

Patricia Paola Gonzalez

2 May 23

Sally E. Blount

2 May 23

Financial summary

Financial statements Chart ABT financial data

Quarter (USD)	Mar 23	Dec 22	Sep 22	Jun 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	9.16 bn	9.16 bn	9.16 bn	9.16 bn	9.16 bn	9.16 bn
Cash burn (monthly)	240.33 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	494.41 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	8.67 bn	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	36.1	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q1 2023

ABT institutional ownership history Ownership history

73.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2592	2692	-3.7%
Opened positions	139	302	-54.0%
Closed positions	239	161	+48.4%
Increased positions	1009	975	+3.5%
Reduced positions	1036	1048	-1.1%

13F shares	Current	Prev Q	Change
Total value	128.53 tn	141.67 tn	-9.3%
Total shares	1.27 bn	1.29 bn	-1.6%
Total puts	6.17 mm	8.31 mm	-25.8%
Total calls	7.05 mm	10.34 mm	-31.8%
Total put/call ratio	0.9	0.8	+8.9%

Largest owners	Shares	Value	Change
Vanguard	155.63 mm	$15.76 tn	+0.1%
BLK Blackrock	135.57 mm	$13.73 tn	-1.7%
Capital Research Global Investors	76.40 mm	$7.74 tn	-0.5%
STT State Street	73.45 mm	$7.44 tn	-1.6%
Capital International Investors	56.43 mm	$5.71 tn	+6.4%
MS Morgan Stanley	36.67 mm	$3.71 tn	-5.9%
Geode Capital Management	31.20 mm	$3.15 tn	+2.0%
NTRS Northern Trust	23.92 mm	$2.42 tn	-0.4%
Massachusetts Financial Services	21.15 mm	$2.14 tn	-14.8%
Wellington Management	20.82 mm	$2.11 tn	+40.5%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0.00	-17.25 mm	EXIT
Ubs Global Asset Management Americas	17.30 mm	+9.00 mm	+108.3%
Wellington Management	20.82 mm	+6.00 mm	+40.5%
Massachusetts Financial Services	21.15 mm	-3.68 mm	-14.8%
BMO Bank of Montreal	0.00	-3.42 mm	EXIT
Capital International Investors	56.43 mm	+3.41 mm	+6.4%
AMP Ameriprise Financial	11.76 mm	-3.36 mm	-22.2%
Capital World Investors	0.00	-3.25 mm	EXIT
Parnassus Investments	0.00	-2.97 mm	EXIT
Jennison Associates	3.53 mm	-2.86 mm	-44.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ABT insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 May 23	Andrea F Wainer	Common shares without par value	Sell	Dispose S	No	No	110.5607	8,226	909.47 k	70,427
2 May 23	Andrea F Wainer	Common shares without par value	Option exercise	Acquire M	No	No	47	8,226	386.62 k	78,653
2 May 23	Andrea F Wainer	Option Common Shares	Option exercise	Dispose M	No	No	47	8,226	386.62 k	0
28 Apr 23	Alpern Robert J	Common shares without par value	Grant	Acquire A	No	No	0	1,816	0.00	37,297
28 Apr 23	Claire Babineaux-Fontenot	Common shares without par value	Grant	Acquire A	No	No	0	1,816	0.00	1,816
28 Apr 23	Blount Sally E.	Common shares without par value	Grant	Acquire A	No	No	0	1,816	0.00	33,157